160 million Nigerians, according to the World Health Organization, are at risk for Yellow Fever.
According to the WHO, with a population of around 200 million, Nigeria accounts for about 25% of all Africans at risk.
Acute viral hemorrhagic disease called yellow fever is spread by infected mosquitoes.
The name’s “yellow” component alludes to the jaundice that some patients experience.
Yellow fever symptoms include fever, headache, jaundice, muscle aches, nauseousness, vomiting, and exhaustion.
Dr. Anne Eudes Jean Baptiste, WHO’s Medical Officer in Nigeria, stated that yellow fever is risky since a small proportion of patients would experience a more toxic stage of the illness. By that time, individuals will have a fever, system failure, primarily in the kidney and liver
The bleeding from the mouth, nose, and eyes may occur, and within 7 to 10 days, half of them will pass away.
Nigeria, according to the WHO, is at danger of contracting the disease in both urban areas and sylvan (jungle) areas.
Yellow fever is spread by sylvatic exposure by mosquitoes that have bitten non-human primates and animals.
These types of transmission are particularly risky for agricultural and mining workers.
After 15 years, yellow fever made a comeback in Nigeria in 2017. The cyclical nature of sylvatic transmission and gaps in disease detection rather than a lack of virus transmission are to blame for this.
. A better understanding of the disease’s distribution in humans is now possible thanks to increased monitoring and laboratory testing.
However, the international health organization said that during the COVID-19 pandemic, Nigeria vaccinated almost 45 million individuals against the disease.
No fewer than 1,005 probable yellow fever cases have been reported in Nigeria so far in 2022.
In 390 Local Government Areas throughout 36 states, including the FCT, instances were reported.
The disease is under closer supervision, according to Dr. Ifedayo Adetifa, Director General of the Nigeria Center for Disease Control.
“We have reference labs across the nation that have been improved, supported, and evaluated to ensure they’re meeting all performance criteria for sample collection and referral to our reference labs in Abuja.
“We distributed almost 66 million pills in 2020 and 2021 to prevent individuals from yellow fever outbreaks despite the ongoing COVID-19 epidemic.
This accomplishment has been made possible by routine immunization as well as massive vaccination drives that aggressively target vulnerable communities and spot demographic shortages, the doctor said.